Previous Close | 14.00 |
Open | 14.00 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 35.00 |
Expire Date | 2024-12-20 |
Day's Range | 14.00 - 14.00 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
DUBLIN, May 28, 2024--Prothena today announced that Bristol Myers Squibb obtained the exclusive global license for PRX019 and will pay Prothena $80 million.
Celebrations may be in order for Prothena Corporation plc ( NASDAQ:PRTA ) shareholders, with the analysts delivering a...
The analysts might have been a bit too bullish on Prothena Corporation plc ( NASDAQ:PRTA ), given that the company fell...